Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Improved risk prediction in HPV-associated endocervical adenocarcinoma through assessment of binary silva pattern-based classification: international multicenter retrospective study of the International Society of Gynecological Pathologists
    Meeting Abstract

    Powell, A.; Hodgson, A.; Cohen, P. A.; Rabban, J.; Park, K.; McCluggage, W. G.; Gilks, C. B.; Contributors From The International Society of Gynecological Pathologists (Isgyp; Singh, N.; Oliva, E.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • A randomized, phase II/III study of pegylated-liposomal-doxorubicin and atezolizumab (IND #134427) versus pegylated-liposomal-doxorubicin, bevacizumab and atezolizumab versus pegylated-liposomal-doxorubicin and bevacizumab in platinum-resistant ovarian cancer (NRG-GY009)
    Meeting Abstract

    O'Cearbhaill, R.; Sill, M.; Duong, H.; Waggoner, S.; Grisham, R.; Backes, F.; Mannel, R.; Tanyi, J.; Powell, M.; Mathews, C.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: Results from the cervical, endometrial, and ovarian cancer cohorts of the destiny-PanTumor02 study
    Meeting Abstract

    Lee, J. Y.; Makker, V.; Manso, L.; González-Martín, A.; Lugowska, I.; Lorusso, D.; Banerjee, S.; Liao, J.; Lu, C. H.; Prasongsook, N.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Selinexor maintenance for patients with TP53WT advanced or recurrent endometrial cancer: Long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
    Meeting Abstract

    Scambia, G.; Vergote, I.; Hamilton, E.; Fidalgo, J. P.; Van Gorp, T.; Sehouli, J.; Klat, J.; Levy, T.; Welch, S.; Richardson, D.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Ubamatamab (MUC16XCD3 bispecific antibody) with or without cemiplimab (anti-PD-1 antibody) in recurrent ovarian cancer: Phase 1 clinical and biomarker results
    Meeting Abstract

    Liu, J.; O'Malley, D.; Van Nieuwenhuysen, E.; Moore, K.; Hamilton, E.; Yeku, O.; Bouberhan, S.; Hou, J.; Schröder, D.; Wang, B.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Durvalumab with paclitaxel/carboplatin + bevacizumab then maintenance durvalumab, bevacizumab + olaparib in patients with newly diagnosed advanced ovarian cancer without a tumour brca1/2 mutation: Results from the DUO-O/ENGOT-OV46/AGO-OVAR 23/GOG-3025 trial
    Meeting Abstract

    Marth, C.; Park-Simon, T. W.; Aghajanian, C.; Reuss, A.; Nishio, S.; Lim, M. C.; Rubio-Pérez, M. J.; Vardar, M. A.; Scambia, G.; Sabatier, R.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Prognosis of surgically staged FIGO IA uterine carcinosarcoma without myometrial invasion: A multicenter international retrospective cohort study
    Meeting Abstract

    Cucinella, G.; Zammarrelli, W. A.; Nasioudis, D.; Capasso, I.; Berretta, R.; Scollo, P.; Francesco, R.; Baiocchi, G.; Barresi, G.; Basilio, P.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of avutometinib plus defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy
    Meeting Abstract

    Grisham, R.; Aghajanian, C.; Van Nieuwenhuysen, E.; Rodrigues, M.; Ring, K.; Santin, A.; Colombo, N.; Prendergast, E.; Thaker, P.; Moore, K.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Near-infrared fluorescence assessment of myocutnaeous flap microperfusion for gynecologic reconstruction (forefront): A prospective, non-randomized trial (NCT05071976)
    Meeting Abstract

    Manning-Geist, B.; Jamner, A.; Leitao, M. M.; Afonso, A.; Mueller, J. J.; Shahzad, F.; Coriddi, M.; Dayan, J.; Burke, E.; Wei, I.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Oncologic outcomes of minimally invasive surgery versus laparotomy for the treatment of apparent uterine-confined clear cell carcinoma
    Meeting Abstract

    Dagher, C.; Sassine, D.; Abu-Rustum, N. R.; Mueller, J. J.; Borach, V.; Zivanovic, O.; Sonoda, Y.; Leitao, M. M.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save